Today’s Pharma Pricing and Reimbursement News from HealthEconomics.Com: Updates for the Pharma and Healthcare Industry

Payers state need for real-world comparative effectiveness research for Specialty Pharmaceuticals. A recent study
found that recruiting patients for Phase IV clinical trials using the Internet could provide valid results. This
and other top healthcare value and health policy stories identified in the just-released HealthEconomics.Com
Newsletter.

You might also be interested in:

New Data, Research Methods Provide Better Insight into Patient… May 28, 2018
ICER Publishes Guidance on Improving Development, Use of RWE… April 11, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
McKesson’s Sarah Alwardt Expands on HEOR, Value of RWE April 4, 2018
Study: EHRs Could Provide Cost-Effective Means for More… May 25, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018
Orphan Drugs: European Payer Perspectives October 14, 2018